- Investing.com
CSPC Innovation Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally. It offers functional raw ingredients, including caffeine, acarbose, anhydrous glucose, theophylline, aminophylline, dihydroxyphylline, theobromine, pentoxifylline, doxofylline, and raw enzymes; and health food products, such as Guoweikang Vitamin C tablets, Guoweikang B vitamin lozenges, etc. The company was founded in 2006 and is headquartered in Shijiazhuang, China. CSPC Innovation Pharmaceutical Co., Ltd. is a subsidiary of CSPC NBP Pharmaceutical Co., Ltd.
Metrics to compare | 300765 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship300765PeersSector | |
---|---|---|---|---|
P/E Ratio | 77.2x | 29.2x | −0.6x | |
PEG Ratio | −11.69 | −0.39 | 0.00 | |
Price/Book | 10.4x | 2.3x | 2.6x | |
Price / LTM Sales | 19.4x | 3.7x | 3.1x | |
Upside (Analyst Target) | 48.5% | 46.0% | 53.1% | |
Fair Value Upside | Unlock | 17.5% | 7.5% | Unlock |